scispace - formally typeset
Journal ArticleDOI

The epidemiology of cervical cancer.

TLDR
The available evidence indicates that the HPV-cervical cancer association satisfies all relevant causal criteria for public health action and is the first instance in which a necessary cause has been demonstrated in cancer epidemiology--a realization that has obvious implications for primary and secondary prevention of this neoplastic disease.
Abstract
Cervical cancer is one of the most common neoplastic diseases affecting women, with a combined worldwide incidence of almost half a million new cases annually, second only to breast cancer. Basic and epidemiologic research conducted during the past 15-20 years have provided overwhelming evidence for an etiologic role for infection with certain types of sexually-transmitted human papillomavirus (HPV) as the primary cause of cervical cancer. The relative risks of cervical cancer following HPV infection as ascertained in case-control and cohort studies are among the highest in cancer epidemiology. The available evidence indicates that the HPV-cervical cancer association satisfies all relevant causal criteria for public health action. Other cervical cancer risk factors, such as smoking, parity, use of oral contraceptives, diet, other infections, and host susceptibility traits must be understood in the context of mediation of acquisition of HPV infection or in influencing events of the natural history of cervical neoplasia that occur following the establishment of a persistent HPV infection. Virtually all cervical carcinoma specimens contain HPV DNA, which suggests that HPV infection is a necessary cause of cervical neoplasia. This is the first instance in which a necessary cause has been demonstrated in cancer epidemiology--a realization that has obvious implications for primary and secondary prevention of this neoplastic disease.

read more

Citations
More filters
Journal ArticleDOI

Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects

TL;DR: Criteria for successful screening is described, recent evidence and policy changes that have implications for cancer screening are discussed, and guidelines reviews that are underway are described.
Journal ArticleDOI

A review of nanocarriers for the delivery of small interfering RNA

TL;DR: This review discusses the recent nanotechnological strategies for siRNA delivery by using different carriers such as liposomes, dendrimers and carbon nanotubes.
Journal ArticleDOI

Advances in diagnosis and treatment of metastatic cervical cancer

TL;DR: For lung metastasis, chemotherapy and/or surgery are valuable treatments for resistant, recurrent metastatic cervical cancer and chemoradiotherapy may be the optimal choice for stage IVB cervical cancer, and Chemotherapy and bone irradiation are promising for bone metastasis.
Journal ArticleDOI

The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.

TL;DR: The authors report on the development and validation of a cervical cancer module for the EORTC Quality‐of‐Life (QoL) questionnaire (QLQ), which was designed to assess disease‐specific and treatment‐specific aspects of QoL in patients with cervical cancer.
Journal ArticleDOI

Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues.

TL;DR: The American Cancer Society (ACS) as mentioned in this paper published a summary of its recommendations for early cancer detection and provided an update of the most recent data pertaining to participation rates in cancer screening from the Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System and the National Health Interview Survey.
References
More filters
Journal ArticleDOI

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

TL;DR: The presence of HPV in virtually all cervical cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer, and the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.
Journal ArticleDOI

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

TL;DR: In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82Should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic.
Journal Article

The environment and disease: association or causation?

TL;DR: This paper contrasts Bradford Hill’s approach with a currently fashionable framework for reasoning about statistical associations – the Common Task Framework – and suggests why following Bradford Hill, 50+ years on, is still extraordinarily reasonable.
Journal ArticleDOI

The causal relation between human papillomavirus and cervical cancer

TL;DR: It is the right time for medical societies and public health regulators to consider the causal role of human papillomavirus infections in cervical cancer and to define its preventive and clinical implications.
Journal ArticleDOI

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

TL;DR: The results confirm the role of genitalHPVs, which are transmitted sexually, as the central etiologic factor in cervical cancer worldwide and suggest that most genital HPVs are associated with cancer, at least occasionally.
Related Papers (5)